Cell and Gene Therapy Business Outlook: Volume 1, Issue 24
10 Jun 2022
Categories:
Cell and Gene Therapy Business Outlook
Don't miss our new twice-monthly publication dedicated to cell and gene therapy. Cell and Gene Therapy Business Outlook offers the following:
- Market Sizing and Forecasting of CAGT Markets
- Executive News Summaries
- Deals Between CAGT Companies Tracked
- Financing
- Trends in the Industry
- Important Science That Will Shape Tomorrow’s Business
- Company Profiling and Quarterly Results Summaries
- Updates on Pipelines and Important Clinical Trials
- Cell and Gene Therapy Tools
- Cell and Gene Therapy CMOs
- And More
Table of Contents
- Untitled Chapter
-
Market Analysis
-
Focus on Transplant Disorders
- Overview of Transplant Disorders
- Market Outlook
- Products on the Market
- Market Size and Growth
- Regional Market
- Products in Development
- Top Company Briefs
- Conclusion
-
Focus on Transplant Disorders
-
Executive News Brief
- Recent developments in cell and gene therapy
-
Recent Funding Deals
- A Look at Cell and Gene Therapy Deals
-
Cell and Gene Therapy Market News and News Analysis
- Immatics and BMS Partner on Allogeneic T Cell Therapies
- Recent CGT Deal Activity